TAVI: current and future perspectives for adjunctive pharmacological therapy

With an unrestricted educational grant from BAYER HEALTHCARE PHARMACEUTICALS

Summary

This video is offered by BAYER HEALTHCARE PHARMACEUTICALS & CARDIALYSIS

Learning Objectives

  • To understand TAVI: patient population characteristics, approved devices and expected clinical outcomes
  • To evaluate current and future antithrombotic therapy options around TAVI
  • To understand future perspectives and upcoming studies

Presentations available when logged in:

  • Session objectives
  • TAVI: a paradigm shift in the treatment of symptomatic, severe aortic stenosis - Past, present and future
  • TAVI-2015: stroke and bleeding risk update
  • Solved and unsolved issues of antithrombotic therapy after TAVI
  • Future perspective and upcoming studies
  • Session evaluation and key learnings